SIRPant Immunotherapeutics to Participate in Wells Fargo Virtual Private Biotech Symposium

Previous PostMekonos Enters Partnership Agreement with Accelerated Biosciences to Develop and Commercialize Engineered Human Trophoblast Stem Cells (hTSCs) for Biomanufacturing